Short term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 1123-1128

  Hoffman, David M ^a   Crampton, Leonie ^a   Sernia, Conrad ^b   Nguyen, Tuan V ^a   Ho, Ken K Y ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTRACELLULAR FLUID; FEMALE; FLUID RETENTION; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOGLYCEMIA; HYPOTHESIS; MALE; ORAL DRUG ADMINISTRATION; PATIENT POSITIONING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SODIUM TRANSPORT; STATISTICAL ANALYSIS;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WATER; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXTRACELLULAR SPACE; FEMALE; GROWTH HORMONE; HEART RATE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; SODIUM; TIME FACTORS;

EID: 0029864191     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.3.1123     Document Type: Article

References (34)

1. Jorgensen JOL, Thuesen L, Ingemann-Hansen T, et al. 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1225.
2. Salomon F, Cuneo RC, Hesp RC, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
3. Whitehead HM, Boreham C, McIlrath EM, et al. 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf). 36:45-52.
4. Binnerts A, Swart GR, Wilson JHP, et al. 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf). 37:79-87.
5. Ludens JH, Bach RR, Williamson HE. 1969 Characteristics of the antinatriuretic action of growth hormone. Proc Soc Exp Biol Med. 130:1156-1158.
6. Biglieri EG, Watlington CO, Forsham PH. 1961 Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab. 21:361-370.
7. Ho KY, Weissberger AJ. 1990 The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism. 39:133-137.
8. Moller J, Jorgensen JOL, Moller N, et al. 1941 Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab. 72:768-772.
9. Jorgensen JOL. 1991 Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr Rev. 12:189-208.
10. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KY. 1994 Diagnosis of growth hormone deficiency in adults. Lancet. 343:1064-1068.
11. Kelly J, Hunyor SN, Ho KY. 1993 Evaluation of ambulatory blood pressure monitoring using Takeda TM-2420 system. Clin Exp Hypertens. 15:271-287.
12. O'Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KKY. 1994 Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab. 78:381-386.
13. Moore FD, Olesen KH, McMurrey JD. The body cell mass and its supporting environment: body composition in health and disease. Philadelphia: Saunders; 1963.
14. Ho KY, Weissberger AJ, Stuart MC, Day RO, Lazarus L. 1989 The pharmacokinetic, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin Endocrinol (Oxf). 30:335-345.
15. Baxter RC, Brown SA, Turtle JR. 1982 Radioimmunoassay for somatomedin-C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem. 28:488-495.
16. Wyse B, Waters M, Sernia C. 1993 Stimulation of the renin-angiotensin system by growth hormone in Lewis dwarf rats. Am J Physiol. 265:E332-E339.
17. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY. 1993 Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf). 39:561-567.
18. Nussberger J, Brunner DB, Waeber B, Brunner HR. 1985 True versus immunoreactive angiotenisn II in human plasma. Hypertension. 7(Suppl 1):1-7.
19. Hartter E, Woloszczuk W, Stummvoll HK. 1986 Radioimmunoassay of atrial natriuretic peptides in human plasma. Clin Chem. 32:441-445.
20. Ott L. 1988 An introduction to statistical methods and data analysis, 3rd ed. Boston: PWS-Kent; 755-790.
21. Valk NK, vd Lely AJ, de Herder WW, Lindmans HJ, Lamberts SWJ. 1994 The effects of human growth hormone (GH) administration in GH-deficient adults: a 20 day metabolic ward study. J Clin Endocrinol Metab. 79:1070-1076.
22. Orme SM, Sebastian JF, Oldroyd B, et al. 1992 Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin Endocrinol (Oxf). 37:453-459.
23. Moller J, Jorgensen JOL, Laurensen T, et al. 1993 Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf). 39:403-408.
24. Snow MH, Piercy DA, Robinson V, Wilkonson R. 1977 An investigation into the pathogenesis of hypertension in acromegaly. Clin Sci Mol Med. 53:87-91.
25. Kelly JJ, Kinloch M, Phillips M, et al. 1991 Sodium homeostasis and blood pressure in acromegaly: relation to growth hormone concentration and effects of sandostatin treatment. Proceedings from the 34th Annual Scientific Meeting of The Endocrine Society of Australia. Sydney: 106 (Abstr 132).
26. Chin E, Zhou J, Bondy CA. 1992 Renal growth hormone receptor gene expression: relationship to renal insulin-like growth factor system. Endocrinology. 131:3061-3066.
27. Harris PJ, Navar LG. 1985 Tubular transport responses to angiotensin. Am J Physiol. 248:F621-F630.
28. Rithcie CM, Sheridan B, Fraser R, et al. 1990 Studies of the pathogenesis of hypertension in Cushing's disease and acromegaly. Q J Med. 76:855-867.
29. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
30. Thuesen L, Christiansen JS, Sorensen KE, et al. 1988 Increased myocardial contractility following growth hormone administration in man. Dan Med Bull. 35:193-196.
31. Cuneo RC, Salomon F, Wilmshurst P, et al. 1991 Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci. 81:587-592.
32. Caidahl K, Eden S, Bengtsson B-A. 1994 Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf). 40:393-400.
33. Jorgensen JOL, Moller J, Laursen T, et al. 1994 Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf). 41:609-614.
34. Sacca L, Cittadini A, Fazio S. 1994 Growth hormone and the heart. Endocr Rev. 15:555-573.